XML 48 R30.htm IDEA: XBRL DOCUMENT
v3.25.1

Stockholders’ Equity (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Stockholders’ Equity [Abstract] |
Schedule of Weighted Average Assumptions used to Estimate the Fair Value of Stock Options and Warrants Granted | The following table reflects the weighted average assumptions used to estimate the fair value of stock options granted during the year ended December 31, 2024:
|  | 2024 |
Volatility |  |  | 110.42 | %
Expected life (years) |  |  | 6.0 |
Risk-free interest rate |  |  | 4.26 | %
Dividend rate |  |  | — | %
The following table reflects the weighted average assumptions used to estimate the fair value of stock warrants granted during the year ended December 31, 2024:
|  | 2024 |
Volatility |  |  | 79.42 | %
Expected life (years) |  |  | 2 |
Risk-free interest rate |  |  | 3.95 | %
Dividend rate |  |  | — | %
Schedule of Stock Option and Warrant Activity | The following table summarizes the stock option activity for the years ended December 31, 2024 and 2023:
|  | Options |  |  | Weighted- Average Exercise Price Per Share |
Outstanding, December 31, 2023 |  |  | - |  |  | $ | - |
Granted |  |  | 235,000 |  |  | $ | 2.02 |
Exercised |  |  | - |  |  | $ | - |
Forfeited |  |  | - |  |  | $ | - |
Expired |  |  | - |  |  | $ | - |
Outstanding and expected to vest, December 31, 2024 |  |  | 235,000 |  |  | $ | 2.02 |
Schedule of Information Regarding Outstanding and Exercisable Options and Warrants | The following table discloses information regarding outstanding and exercisable options at December 31, 2024:
|  |  | Outstanding |  |  | Exercisable |
Exercise Price Range |  |  | Number of Option Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Life (Years) |  |  | Number of Option Shares |  |  | Weighted Average Exercise Price |
$ | 2.02 |  |  |  | 235,000 |  |  | $ | 2.02 |  |  |  | 9.19 |  |  |  | - |  |  | $ | - |
|  |  |  |  | 235,000 |  |  | $ | 2.02 |  |  |  | 9.19 |  |  |  | - |  |  | $ | - |
The following table discloses information regarding outstanding and exercisable warrants at December 31, 2024:
|  |  | Outstanding |  |  | Exercisable |
Exercise Price Range |  |  | Number of Warrant Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Life (Years) |  |  | Number of Warrant Shares |  |  | Weighted Average Exercise Price |
$ | 0.75 |  |  |  | 1,200,000 |  |  | $ | 0.75 |  |  |  | 1.80 |  |  |  | 1,200,000 |  |  | $ | 0.75 |
$ | 11.50 |  |  |  | 14,714,000 |  |  | $ | 11.50 |  |  |  | 3.77 |  |  |  | 14,714,000 |  |  | $ | 11.50 |
|  |  |  |  | 15,914,000 |  |  |  | 10.69 |  |  |  | 3.62 |  |  |  | 15,914,000 |  |  |  | 3.62 |
Schedule of Summarizes the Stock Warrant Activity | The following table summarizes the stock warrant activity for the years ended December 31, 2024 and 2023:
|  | Warrants |  |  | Weighted- Average Exercise Price Per Share |
Outstanding and exercisable, January 1, 2023 |  |  | - |  |  | $ | - |
Granted |  |  | 14,564,000 |  |  | $ | 11.50 |
Exercised |  |  | - |  |  | $ | - |
Forfeited |  |  | - |  |  | $ | - |
Expired |  |  | - |  |  | $ | - |
Outstanding, December 31, 2023 |  |  | 14,564,000 |  |  | $ | 11.50 |
Granted |  |  | 1,650,000 |  |  | $ | 2.82 |
Exercised |  |  |  |  |  | $ | - |
Forfeited |  |  | (300,000 | ) |  | $ | 11.50 |
Expired |  |  | - |  |  | $ | - |
Outstanding and expected to vest, December 31, 2024 |  |  | 15,914,000 |  |  | $ | 10.69 |

X
- References No definition available. + Details
Name: | us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration